Adverse Cases
- Adverse reactions with botulinum toxin A (Botox, Dysport)
- More Data Support Adverse Clopidogrel and PPI Interaction
- Risks of fulminant liver failure when stopping drugs for the management of hepatitis B
- Modafinil: adverse skin and psychiatric reactions
- Varenicline: The Australian experience so far
- Drug-induced hyponatraemia
- Fluoroquinolone antibiotics and tendon disorders: still a problem
- Fatal interactions and reactions with colchicine: beware CYP3A4 inhibitors
- Desmopressin and hyponatraemia
- High-dose vitamin B6 may cause peripheral neuropathy
- Hepatic toxicity with nitrofurantoin
- Statins and muscle disorders – be careful with the dose
- Severe skin reactions and venous thromboembolism with strontium ranelate (Protos)
- Topiramate and other drugs causing glaucoma
- MRI scans with gadolinium-containing contrast agents and the risk of NSF – caution in patients with renal impairment
- Nicorandil-associated ulceration
- Hepatic reactions with terbinafine
- Interaction between glucosamine and warfarin
- Transdermal medications - look for the patch
- Reports of hypersensitivity reactions to pregabalin
- Erythropoietins: aim for lower haemoglobin levels
- Emerging cardiovascular concerns with rosiglitazone
- Dangers associated with chronic ingestion of colloidal silver
- Renal impairment with zoledronic acid
- Thiazolidinediones and reduced bone density
- Atypical antipsychotic agents and extrapyramidal side effects
- Implanon: interactions and failure of contraception
- Rituximab and progressive multifocal leukoencephalopathy
- Black cohosh and liver toxicity – an update
- Mirtazapine and blood dyscrasias